Clinical Trial Update: An Open-label, Clinical Feasibility Study of the Efficacy of Remdesivir for Long-COVID. [Phase 4]

View source ↗

Summary

A Phase 4 open-label feasibility study evaluating remdesivir for Long COVID has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Long Covid
• Post-acute Sequelae of Sars-cov-2 Infection

Drugs mentioned

• Remdesivir (Veklury) (Remdesivir)

Snippet

Sponsor: University of Derby | Conditions: SARS-CoV-2 Infection, COVID-19 | Phase 4 | Status: COMPLETED